Evidence map›Paper›PMID 24706823›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Nkx6.1 regulates islet β-cell proliferation via Nr4a1 and Nr4a3 nuclear receptors.

Jeffery S Tessem, Larry G Moss, Lily C Chao, Michelle Arlotto, Danhong Lu, Mette V Jensen, Samuel B Stephens, Peter Tontonoz, Hans E Hohmeier, Christopher B Newgard

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Nr4a1 β-cell specific deletion impairs glucose tolerance in female mice.American journal of physiology. Endocrinology and metabolism · 2026
    Article
  3. Establishment of a mInternational journal of genomics · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO/NR4A3 axis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jeffery S TessemSarah W. Stedman Nutrition and Metabolism Center, Duke Molecular Physiology Institute, Department of Pharmacology and Cancer Biology, and Department of Medicine, Division of Endocrinology, Duke University Medical Center, Durham, NC 27704.
Larry G Moss
Lily C Chao
Michelle Arlotto
Danhong Lu
Mette V Jensen
Samuel B Stephens
Peter Tontonoz
Hans E Hohmeier
Christopher B Newgard
Duke Medical Center · USHoward Hughes Medical Institute · USDuke University Hospital · US

Funding

Multi-Disciplinary Approaches to Driving Therapeutic Human Beta Cell ReplicationU01DK089538 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEWART, ANDREW F. · 2010 to 2014
$3.6M
Howard Hughes Medical InstituteNIDDK NIH HHS U01 DK-089538NIDDK NIH HHS U01 DK089538
6 · The paper itself

Abstract

Loss of functional β-cell mass is a hallmark of type 1 and type 2 diabetes, and methods for restoring these cells are needed. We have previously reported that overexpression of the homeodomain transcription factor NK6 homeobox 1 (Nkx6.1) in rat pancreatic islets induces β-cell proliferation and enhances glucose-stimulated insulin secretion, but the pathway by which Nkx6.1 activates β-cell expansion has not been defined. Here, we demonstrate that Nkx6.1 induces expression of the nuclear receptor subfamily 4, group A, members 1 and 3 (Nr4a1 and Nr4a3) orphan nuclear receptors, and that these factors are both necessary and sufficient for Nkx6.1-mediated β-cell proliferation. Consistent with this finding, global knockout of Nr4a1 results in a decrease in β-cell area in neonatal and young mice. Overexpression of Nkx6.1 and the Nr4a receptors results in increased expression of key cell cycle inducers E2F transcription factor 1 and cyclin E1. Furthermore, Nkx6.1 and Nr4a receptors induce components of the anaphase-promoting complex, including ubiquitin-conjugating enzyme E2C, resulting in degradation of the cell cycle inhibitor p21. These studies identify a unique bipartite pathway for activation of β-cell proliferation, suggesting several unique targets for expansion of functional β-cell mass.

Indexed as

Cell ProliferationAnimalsAnimals, NewbornChromatin ImmunoprecipitationDNA-Binding ProteinsHomeodomain ProteinsIslets of LangerhansMaleMice, KnockoutNerve Tissue ProteinsNuclear Receptor Subfamily 4, Group A, Member 1Oligonucleotide Array Sequence AnalysisRatsRats, WistarRNA, MessengerUbiquitin-Conjugating EnzymesDNA-Binding ProteinsHomeodomain ProteinsNerve Tissue ProteinsNkx6-1 protein, ratNr4a1 protein, ratNr4a3 protein, ratNuclear Receptor Subfamily 4, Group A, Member 1RNA, MessengerUbiquitin-Conjugating Enzymes

Identifiers

PMID24706823
PMCPMC3986138
OpenAlexW2163616479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.